(1)
GUVVALI, D.; MOHANTY, D. A QUALITY BY DESIGN DRIVEN DEVELOPMENT AND CHARACTERIZATION OF PALBOCICLIB-LOADED MESOPOROUS SILICA NANOPARTICLES IN HEPATOCELLULAR CARCINOMA THERAPY: ASSESSMENT OF CYTOTOXIC AND APOPTOTIC EFFECTS ON HEPG2 CELL LINE. Int J App Pharm 2026, 18.